No Data
No Data
European Medicines Agency Accepts Deciphera's Marketing Authorization Application for Vimseltinib for Treatment of Patients With Tenosynovial Giant Cell Tumor (TGCT)
- Application based on results from the MOTION Phase 3 study, in which vimseltinib demonstrated statistically significant and clinically meaningful improvement in objective response rate compared to
Chordia - 3Q is making steady progress in the research and development of CLK inhibitors, such as CTX-712.
Chordia Therapeutics <190A> announced its Q3 2024 (September 2023-May 2024) financial results on the 16th. The business revenue was not applicable, and the operating loss, ordinary loss, and quarterly net loss were 1.18 billion yen, 1.175 billion yen, and 1.177 billion yen, respectively. As financial statements for Q3 2023 have not been created, the change rate from the same quarter of the previous year is not reported for Q3 2024. The company has achieved unprecedented success.
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
List of stocks that are breaking through the clouds in the market: Code, Company name, closing price, leading span A, leading span B. Tokyo Stock Exchange Prime: <1813>, Fudote-Tetra, 2452, 2448.25, 2274.5; <1871>, P.S., 1026, 1016.25, 1015; <1898>, Seiko Tokyu, 1774, 1676.25, 1773. <1944>
Chordia --- won the Innovation Award 2024.2Q sponsored by Mizuho Bank.
Chordia Therapeutics <190A> announced that it has been selected as a winning company in the 'Mizuho Innovation Award 2024.2Q', in which Mizuho Bank, a group company of Mizuho Financial Group <8411>, awards promising innovative companies every quarter. As a recipient of the 'Mizuho Innovation Award', the company will be provided with business opportunities with large corporations from Mizuho Bank.
Sumitomo Riko, Shionogi, etc. (additional) rating.
Upgrade-Power Code | Stock Name | Securities Company | Previous | After changing | ------ | --------------- | ------------- | -------------- | -------------- | <2212> | Yamazaki Bread | GS | "Hold" | "Buy" | <4293> | Septeni HD | MSMUFG | "UnderW" | "Iko"
I-ne, Ono Pharmaceutical Industries, etc. (added) Rating.
Upgrade - Bullish Code | Stock Name | Securities Company | Conventional | Revised | ------ | ------------------- | ----------- | ------- | ------- | <1911> | Sumitomo Forestry Co., Ltd. | SMBC Nikko | "2" | "1" | Target share price change code | Stock Name | Securities Company | Conventional | Revised | ------ | ------------------- |
No Data